{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T02:26:24Z","timestamp":1781490384637,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ijantimicag.2018.12.003","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T02:26:32Z","timestamp":1545013592000},"page":"423-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia"],"prefix":"10.1016","volume":"53","author":[{"given":"Eli","family":"Ben-Chetrit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Abed","family":"Eldaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maskit","family":"Bar-Meir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutaz","family":"Dodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0001","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1469-0691.2005.01298.x","article-title":"Risk of bacteraemia and mortality in patients with haematological malignancies","volume":"12","author":"Norgaard","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0002","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1086\/502158","article-title":"Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case\u2013control study","volume":"24","author":"Wisplinghoff","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0003","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","article-title":"Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance","volume":"32","author":"Montassier","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0004","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2009.02.002","article-title":"Incidence and clinical impact of extended-spectrum-betalactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies","volume":"58","author":"Trecarichi","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkp411","article-title":"Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome","volume":"65","author":"Gudiol","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0006","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00277-011-1247-7","article-title":"Risk factors for infection and treatment outcome of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy","volume":"91","author":"Kang","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0007","doi-asserted-by":"crossref","first-page":"e35780","DOI":"10.1371\/journal.pone.0035780","article-title":"Molecular analysis and risk factors for Escherichia coli producing extended-spectrum \u03b2-lactamase bloodstream infection in hematological malignancies","volume":"7","author":"Cornejo Juarez","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0008","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00277-012-1631-y","article-title":"Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum b-lactamase production and its impact on outcome","volume":"92","author":"Kim","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0009","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijantimicag.2013.07.018","article-title":"Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum b-lactamase-producing Escherichia coli in patients with cancer","volume":"42","author":"Ha","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0010","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1128\/AAC.00044-07","article-title":"Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome","volume":"51","author":"Daikos","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0011","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2334-6-24","article-title":"Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum b-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence","volume":"6","author":"Marra","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0012","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/00365540151060806","article-title":"Clinical significance and impact on mortality of extended-spectrum b lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia","volume":"33","author":"Menashe","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0013","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkn514","article-title":"Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome","volume":"63","author":"Ortega","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0014","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/jhin.2000.0862","article-title":"An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum \u03b2-lactamase","volume":"47","author":"Pena","year":"2001","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0015","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jac\/dks065","article-title":"Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis","volume":"67","author":"Rottier","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0016","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Infectious Diseases Society of America Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0017","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0018","series-title":"Performance standards for antimicrobial susceptibility testing; Twenty-first informational supplement; M100-S21","year":"2011"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0019","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.diagmicrobio.2004.07.007","article-title":"Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study","volume":"50","author":"Chatzinikolaou","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0020","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/508877","article-title":"Bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge","volume":"43","author":"Rodr\u0131guez-Ban\u00f5","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0021","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1469-0691.2005.01358.x","article-title":"Risk-factors for acquisition of extended-spectrum b-lactamase producing Escherichia coli among hospitalised patients","volume":"12","author":"Pena","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0023","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.ijantimicag.2018.12.003_bib0024","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cmi.2018.03.008","article-title":"Prevalence of carriage of extended-spectrum \u03b2-lactamase-producing enterobacteria and associated factors in a French hospital","volume":"24","author":"Jolivet","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cmi.2014.09.014","article-title":"Predicting carriage with extended-spectrum beta-lactamase-producing bacteria at hospital admission: a cross-sectional study","volume":"21","author":"Platteel","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0026","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhin.2013.07.014","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage upon hospital admission: prevalence and risk factors","volume":"85","author":"Shitrit","year":"2013","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0027","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ajic.2015.02.030","article-title":"Risk factors for bloodstream infection caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime","volume":"43","author":"Chopra","year":"2015","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0028","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1590\/S1413-86702011000600016","article-title":"Klebsiella ESBL bacteremia-mortality and risk factors","volume":"15","author":"Tuon","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0029","doi-asserted-by":"crossref","DOI":"10.1017\/ice.2016.292","article-title":"Clinical risk score for prediction of extended-spectrum \u03b2-lactamase-producing enterobacteriaceae in bloodstream isolates","volume":"38","author":"Augustine","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0030","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E. coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0031","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkm318","article-title":"Mortality and delay in effective therapy associated with extended-spectrum \u03b2-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis","volume":"60","author":"Schwaber","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ijantimicag.2018.12.003_bib0032","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jmii.2017.05.006","article-title":"Propensity-matched analysis of the impact of extended-spectrum \u03b2-lactamase production on adults with community-onset Escherichia coli, Klebsiella species, and Proteus mirabilis bacteremia","volume":"51","author":"Lee","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"10.1016\/j.ijantimicag.2018.12.003_bib0033","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s15010-018-1151-3","article-title":"Prognostic factors and scoring model of hematological malignancies patients with bloodstream infections","volume":"46","author":"Tang","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2018.12.003_bib0034","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/rccm.201703-0621ED","article-title":"Antibiotics for Sepsis: Does Each Hour Really Count, or Is It Incestuous Amplification?","volume":"196","author":"Singer","year":"2017","journal-title":"Am J Respir Crit Care Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918303650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918303650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T06:37:23Z","timestamp":1565764643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918303650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0924857918303650"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.12.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}